Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Public awareness of multiple sclerosis (MS) is set for a boost this week thanks to a new campaign from the MS Society. A television advert starring people living with the condition aired last night...
A new drug has shown promising results in a phase three trial for relapsing remitting multiple sclerosis (RRMS). Ponesimod significantly reduced relapse rate, new active lesions and fatigue when...
A common diabetes drug may offer hope of a new treatment for multiple sclerosis (MS) after an animal study showed it can repair nerve damage caused by the condition. Researchers at Cambridge...
A study has suggested higher intakes of whole grains and legumes could have a possible protective role against neuromyelitis optica spectrum disorder (NMO), also known as Devic’s disease. The...
Many people diagnosed with multiple sclerosis (MS) are of childbearing age, therefore, in a bid to understand any important family planning concerns they might have, researchers have surveyed a...
Benign multiple sclerosis (MS) is defined as patients that are fully functional in all neurologic systems after 15 years of onset. Amato described the most commonly used definition of patients not...
Detecting changes to the brain’s central vein using magnetic resonance imaging (MRI) scans is a useful and accurate strategy to enhance diagnosis of MS, a new study shows. Analysis of more than 4,000...
The first clinical trial of EHP-101, an investigational cannabinoid derived treatment for multiple sclerosis (MS), has been successfully completed. EHP-101 is a synthetic derivative compound of...
Researchers from a Scottish university have compared two commonly used treatments for foot drop - functional electrical stimulation (FES) and ankle-foot orthosis (AFO) - but found little difference...
New research, published in the journal Nature, demonstrates that it is possible to restore older brain stem cells to a younger, healthier state – something that may help them to remyelinate. A multi-...

Pages